-
Israel says killed Iran intel chief, tells military to hunt down officials
-
China tech giant Tencent bets on AI agents
-
AFCON stripping of Senegal's title a 'disgrace for Africa' say fans
-
Japan thrash South Korea 4-1 to set up Women's Asian Cup final with Australia
-
Fernandez uncertain over Chelsea future after Champions League exit
-
Iran women's football team arrive in eastern Turkey, heading home
-
Russia slams Oscar-winning anti-Putin documentary
-
Mass burials expected for victims of Kabul drug rehab centre strike
-
Celtic keeper Schmeichel fears shoulder injury could end his career
-
Israelis shelter with pets from threat of Iran missiles
-
Deadly strikes across Mideast as Iran vows revenge on slain security chief
-
Japan, S. Korea petrochemical industry slows output on Iran war
-
Chinese tourists ditch Japan for third month running
-
Record setters Duplantis, Hodgkinson headline Torun world indoors
-
Chinese visitors to Japan plunge 45.2% in February
-
BTS light stick prices surge ahead of comeback concert
-
'Special human' Slipper to break Super Rugby appearance record
-
Brussels to unveil 'EU Inc' pan-European company status
-
Iran to hold funeral for slain security chief as it vows vengeance
-
Greenland's teenage boxers throwing punches to survive
-
TotalEnergies faces ruling in Belgian farmer climate case
-
Brazil starts to restrict minors' access to social media
-
Trespasser caught in viral hippo Moo Deng's Thai zoo pen
-
Gilgeous-Alexander scores 40 as Thunder clinch playoff berth
-
Venezuela stun United States to win World Baseball Classic
-
Stocks extend gains and oil dips as US, Israel, Iran continue strikes
-
Iran missile fire kills two in central Israel: medics
-
Britain, Rwanda in £100m court clash over migrant deal
-
'We will wait for each one': Ukrainians greet POWs with tears and cheers
-
UN watchdog says projectile struck Iran nuclear power plant
-
Trump faces impasse over Iran war
-
US Fed expected to hold rates steady as Iran war's shockwaves ripple
-
Former Australian Test wicketkeeper Haddin to coach NSW
-
China coach says team on right track despite Asian Cup heartache
-
Oscars audience drops, viewing figures show
-
Resilient Australia 'need to be better' in Women's Asian Cup final
-
Gio Reyna picked for US squad as Pochettino says World Cup roster still 'open'
-
Colombia, Ecuador leaders clash over bomb dropped near border
-
Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst
-
SUZUME Tools Expands Core Product Line to Meet Growing Demand From Tool Enthusiasts and Professionals
-
Irving Resources Receives Assay Results from Its Shika Epithermal Au-Ag Prospect and Announces Its 2026 Exploration Plans for the Noto Peninsula, Honshu, Japan
-
Event Marketer to Measure Attendee Engagement with FastSensor at the Experiential Marketing Summit 2026
-
Inventus Reports $1.16 Million in Gold Sales and 102% Return on Bulk Sample Cost at Pardo
-
Ryde Group Ltd Executes Strategic Shift to Digital Asset Treasury to Maximize Capital Efficiency and Resilience
-
Modern Mingle Wins 2026 Consumer Choice Award for Dating Services in San Antonio
-
HawkSearch by Bridgeline Wins Industrial Distribution Customer to Deliver, AI-Powered, On-Site Search
-
APCO Recognized With 2026 Consumer Choice Award for Exterior Home Improvement Excellence in Columbus
-
Gibbs Landscape Company Wins 2026 Consumer Choice Award in Atlanta
-
One Hour Heating & Air Conditioning Wins 2026 Consumer Choice Award for Air Conditioning and Heating Contractor in Charlotte
-
Home-Tite Pest Control & Proofing Wins 2026 Consumer Choice Award for Pest Control in Waterloo
US judges appear skeptical of preserving access to abortion pill
A US federal appeals court panel appeared skeptical on Wednesday of preserving access to a widely used abortion pill.
The three conservative judges pushed back against government arguments that the decision on whether to allow the use of mifepristone should be left to the Food and Drug Administration (FDA), which approved the drug more than 20 years ago.
"We are allowed to look at the FDA just like we're allowed to look at any agency," said Judge James Ho. "That's the role of the courts."
Anti-abortion groups are seeking to have mifepristone banned, claiming despite its long track record that it is unsafe. The case is the latest skirmish in the battle over reproductive rights in the United States.
Ho and one of the other judges on the panel of the New Orleans-based 5th Circuit Court of Appeals were appointed by former president Donald Trump, while the third was also named by a Republican president, George W. Bush.
All three judges seemed unconvinced by arguments by the Justice Department of Democratic President Joe Biden and lawyers for mifepristone manufacturer Danco that the drug should be allowed to remain on the market.
The case stems from a ruling by a conservative US District Court judge in Texas that would have banned mifepristone, which accounts for more than half of the abortions in the United States.
The 5th Circuit Court blocked a ban on the abortion pill, but imposed tough restrictions on access, after which the baton was handed to the Supreme Court, where conservatives wield a 6-3 majority.
The Supreme Court temporarily preserved access to mifepristone, freezing the rulings by the lower courts, and sent the case back to the 5th Circuit.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, was pessimistic following Wednesday's hearing.
"The arguments today demonstrated in detail that the case has no legal or scientific merit and should have been laughed out of court from the very start," Dalven said.
"Unfortunately, the deck is stacked as the judges hearing this case are well known for their extraordinary hostility to abortion," Dalven said.
Any ruling by the appellate court is likely to eventually reach the Supreme Court, which overturned the constitutional right to abortion 11 months ago.
Since then, more than a dozen states have banned abortion and it has been severely restricted in others.
Mifepristone is one component of a two-drug regimen that can be used through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved in 2000.
B.Finley--AMWN